• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, July 26, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Novel immunotherapy mechanism suppresses breast cancer development

Bioengineer by Bioengineer
June 3, 2022
in Biology
Reading Time: 1 min read
0
Novel immunotherapy mechanism suppresses breast cancer development
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Novel immunotherapy mechanism suppresses breast cancer development

Credit: Emanuela Marchese, PhD



Journal

Journal of Experimental Medicine

DOI

10.1084/jem.20201963

Method of Research

Experimental study

Subject of Research

Animals

Article Title

CD4+ T helper 2 cells suppress breast cancer by inducing terminal differentiation

Article Publication Date

3-Jun-2022

COI Statement

Disclosures: M. Boieri is an employee of Zelluna Immunotherapy. S. Iyer is an employee of and has equity in Verve Therapeutics. M.N. Rivera reported grants from Advanced Cell Diagnostics and non-financial support from Merck/Serono outside the submitted work. No other disclosures were reported.

Share12Tweet8Share2ShareShareShare2

Related Posts

T-Cell Engagers: Balancing Activity and Safety in Engineering Designs

T-Cell Engagers: Balancing Activity and Safety in Engineering Designs

July 26, 2026
SPF2 and SGO2/CTF18 limit centromere-near crossovers by regulating SUMOylation

SPF2 and SGO2/CTF18 limit centromere-near crossovers by regulating SUMOylation

July 26, 2026

Gene transfer between infecting bacteria drives extreme antibiotic resistance in lungs

July 26, 2026

Biomolecular Condensates Act as Unexpected Catalysts, Study Finds

July 26, 2026

POPULAR NEWS

  • Cerebral Venous Flow Controls Brain Pressure and Clearance Through Meningeal Lymphatics

    29 shares
    Share 12 Tweet 7
  • Metasurface Platform Enables Independent, Concurrent Emissivity Control in MWIR and LWIR

    29 shares
    Share 12 Tweet 7
  • Lipids in Ovarian Cancer Ascites Impair T Cell Activation by Disturbing TCR Dynamics

    29 shares
    Share 12 Tweet 7
  • Mass Spectrometry Imaging Tracks Different Starting Steps of Benzalkonium Degradation

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Cerebral Venous Flow Controls Brain Pressure and Clearance Through Meningeal Lymphatics

Metasurface Platform Enables Independent, Concurrent Emissivity Control in MWIR and LWIR

Lipids in Ovarian Cancer Ascites Impair T Cell Activation by Disturbing TCR Dynamics

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.